EA200600471A1 - Лечение устойчивости к аспирину с использованием radix salviae multiorrhizae, его экстракта и композиции - Google Patents

Лечение устойчивости к аспирину с использованием radix salviae multiorrhizae, его экстракта и композиции

Info

Publication number
EA200600471A1
EA200600471A1 EA200600471A EA200600471A EA200600471A1 EA 200600471 A1 EA200600471 A1 EA 200600471A1 EA 200600471 A EA200600471 A EA 200600471A EA 200600471 A EA200600471 A EA 200600471A EA 200600471 A1 EA200600471 A1 EA 200600471A1
Authority
EA
Eurasian Patent Office
Prior art keywords
aspirin
extract
treatment
composition
multiorrhizae
Prior art date
Application number
EA200600471A
Other languages
English (en)
Other versions
EA010910B1 (ru
Inventor
Ксицзунь Ян
Наифэнг Ву
Чжэнглянг Йе
Ксу Ли
Чжиксинь Гуо
Цзунь Чжэнг
На Чжао
Original Assignee
Тианцзинь Тейсли Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34621020&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200600471(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CNB031552757A external-priority patent/CN100391486C/zh
Priority claimed from CNB2004100198381A external-priority patent/CN100411641C/zh
Application filed by Тианцзинь Тейсли Фармасьютикал Ко., Лтд. filed Critical Тианцзинь Тейсли Фармасьютикал Ко., Лтд.
Publication of EA200600471A1 publication Critical patent/EA200600471A1/ru
Publication of EA010910B1 publication Critical patent/EA010910B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к лечению устойчивых к аспирину сердечно- и церебрально-сосудистых заболеваний с применением RSM, его экстракта и композиции, включающей любой один из них или оба, особенно формулировку драже даншен (Dan Shen, драже RSM).
EA200600471A 2003-08-28 2004-08-26 Лечение устойчивости к аспирину с использованием radix salviae miltiorrhizae, его экстракта и композиции EA010910B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB031552757A CN100391486C (zh) 2003-08-28 2003-08-28 复方丹参滴丸在制备治疗阿司匹林抵抗性心血管疾病的药物中的应用
CNB2004100198381A CN100411641C (zh) 2004-06-30 2004-06-30 一种滴丸剂在制备治疗阿司匹林抵抗药物中的应用
PCT/CN2004/000989 WO2005049058A1 (fr) 2003-08-28 2004-08-26 Radix salviae miltiorrhizae, extrait et composition destines au traitement des maladies de resistance a l'aspirine

Publications (2)

Publication Number Publication Date
EA200600471A1 true EA200600471A1 (ru) 2006-08-25
EA010910B1 EA010910B1 (ru) 2008-12-30

Family

ID=34621020

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600471A EA010910B1 (ru) 2003-08-28 2004-08-26 Лечение устойчивости к аспирину с использованием radix salviae miltiorrhizae, его экстракта и композиции

Country Status (14)

Country Link
US (2) US20070071837A1 (ru)
EP (1) EP1658879B1 (ru)
JP (1) JP2007504099A (ru)
KR (1) KR101210405B1 (ru)
AU (1) AU2004290484B8 (ru)
CA (1) CA2537300C (ru)
DK (1) DK1658879T3 (ru)
EA (1) EA010910B1 (ru)
ES (1) ES2405599T3 (ru)
HK (1) HK1092090A1 (ru)
MY (1) MY143282A (ru)
NO (1) NO335203B1 (ru)
PT (1) PT1658879E (ru)
WO (1) WO2005049058A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005044289A2 (en) * 2003-11-07 2005-05-19 Cognis France, S.A.S. An extract of the fruit of schisandra chinensis and its pharmaceutical and cosmetic use
MY147497A (en) * 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract
GB2439046B (en) * 2006-06-16 2010-12-08 Phynova Ltd Antiviral product
WO2010111935A1 (zh) * 2009-03-30 2010-10-07 天津天士力制药股份有限公司 一种新的丹酚酸化合物l、其制备方法和用途
US20120148685A1 (en) * 2009-06-10 2012-06-14 Engergy4Life AG Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
CN102160872A (zh) 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
MY172154A (en) * 2012-08-29 2019-11-14 Biotropics Malaysia Berhad Composition for cognition and cosmetic purposes and use of said composition for preparing an agent
CN103099896B (zh) * 2013-01-06 2014-10-01 车艳艳 治疗心脑血管疾病的药茶
CN103169777B (zh) * 2013-02-07 2014-09-10 江苏七○七天然制药有限公司 一种治疗心血管疾病的中药胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
WO2001031052A1 (en) * 1999-10-25 2001-05-03 Colorado Coagulation Consultants Thromboxane b2 metabolite and methods for regulating aspirin-related platelet action
JP2001354579A (ja) * 2000-06-15 2001-12-25 Lion Corp 抗炎症化粧料
US8486464B2 (en) * 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
BRPI0116589B1 (pt) * 2000-12-22 2018-07-03 Tasly Pharmaceutical Group Co., Ltd. Composição herbal para angina pectoris, método para prepará-la e uso desta
US20050037094A1 (en) * 2003-07-31 2005-02-17 Xijun Yan Composition for heart disease, its active ingredients, method to prepare same and uses thereof

Also Published As

Publication number Publication date
US20080305189A1 (en) 2008-12-11
DK1658879T3 (da) 2013-05-13
US20070071837A1 (en) 2007-03-29
WO2005049058A1 (fr) 2005-06-02
PT1658879E (pt) 2013-04-08
MY143282A (en) 2011-04-15
AU2004290484A1 (en) 2005-06-02
EP1658879B1 (en) 2013-02-20
EA010910B1 (ru) 2008-12-30
NO20060832L (no) 2006-02-21
AU2004290484B2 (en) 2010-03-25
CA2537300A1 (en) 2005-06-02
KR101210405B1 (ko) 2012-12-10
KR20070017944A (ko) 2007-02-13
ES2405599T3 (es) 2013-05-31
EP1658879A1 (en) 2006-05-24
CA2537300C (en) 2013-07-30
JP2007504099A (ja) 2007-03-01
WO2005049058A8 (fr) 2005-08-11
AU2004290484B8 (en) 2010-05-13
NO335203B1 (no) 2014-10-20
HK1092090A1 (en) 2007-02-02
EP1658879A4 (en) 2008-11-26

Similar Documents

Publication Publication Date Title
EA200600636A1 (ru) Фармацевтическая композиция для лечения сердечно-сосудистых и цереброваскулярных заболеваний
EA201070544A1 (ru) Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
HK1092090A1 (en) Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases
BRPI0512352A (pt) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimiocinas
DE60206137D1 (de) Kräuterpflanzen enthaltende artzneimittel
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA200700362A1 (ru) Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью
CL2007002610A1 (es) Compuestos derivados de bipiridina sustituida; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento y/o la profilaxis de enfermedades tales como hipertonia, diabetes, infarto de miocardio, entre otras.
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
EA200870019A1 (ru) Лактамовые соединения и способы их применения
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
DK1713490T3 (da) Sammensætninger til behandling af atopisk dermantitis, allergiske hudsygdomme og akne
EA201170353A1 (ru) Антитела против гепатита с и их применение
DK1680128T3 (da) Myo-inositolhexaphosphat til topisk anvendelse
CL2012000097A1 (es) Compuestos derivados de 3-fenoximetilpirrolidina, inhibidores de la recaptacion de serotonina-norepinefrina; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica que lo comprende; y su uso en el tratamiento de trastornos del dolor, depresion, entre otros.
NO20076405L (no) Anvendelse av 24-nor-UDCA
CL2023000491A1 (es) Composiciones de erenumab y usos de las mismas (divisional de solicitud n° 02519-2020).
EA200701688A1 (ru) Замещённые пирролы, содержащие их композиции, способ получения и применение
FR2842422B1 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
EA201490752A1 (ru) Композиция, включающая сцирпусин a и сцирпусин b, и ее способность препятствовать развитию ожирения
DE602004025103D1 (de) Heilkräuterzusammensetzung zur Behandlung von AIDS

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

TC4A Change in name of a patent proprietor in a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU